Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Fulvestrant in Locally Advanced Malignant Solid Neoplasm: NCT06997029 Clinical Landscape Report 2026
16 October 2026
NCT06997029 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Izalontamab Brengitecan in Platinum-Resistant Primary Peritoneal Carcinoma: NCT06994195 Clinical Landscape Report 2026
16 October 2026
NCT06994195 clinical landscape for Platinum-Resistant Primary Peritoneal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
9 min read
Cannabidiol in prurigo nodularis: NCT06994520 Clinical Landscape Report 2026
16 October 2026
NCT06994520 clinical landscape for prurigo nodularis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HSK-44459 in Dermatitis, Atopic: NCT06996912 Clinical Landscape Report 2026
16 October 2026
NCT06996912 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Florquinitau F18 in Alzheimer Disease: NCT06999434 Clinical Landscape Report 2026
16 October 2026
NCT06999434 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cadonilimab in Uterine Cervical Cancer: NCT06998394 Clinical Landscape Report 2026
16 October 2026
NCT06998394 clinical landscape for Uterine Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Roflumilast in Dermatitis, Atopic: NCT06998056 Clinical Landscape Report 2026
16 October 2026
NCT06998056 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Deucravacitinib in Pustulosis of Palms and Soles: NCT07000630 Clinical Landscape Report 2026
16 October 2026
NCT07000630 clinical landscape for Pustulosis of Palms and Soles: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zumilokibart in Dermatitis, Atopic: NCT07003425 Clinical Landscape Report 2026
16 October 2026
NCT07003425 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Iparomlimab/Tuvonralimab in Ovarian clear cell carcinoma: NCT07002346 Clinical Landscape Report 2026
16 October 2026
NCT07002346 clinical landscape for Ovarian clear cell carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Resecabtagene Autoleucel in Multiple Sclerosis, Chronic Progressive: NCT07006805 Clinical Landscape Report 2026
16 October 2026
NCT07006805 clinical landscape for Multiple Sclerosis, Chronic Progressive: endpoints, sponsor, phase, geography, readouts, asset context and development whi…
9 min read
RG-6540 in Multiple Sclerosis: NCT07008378 Clinical Landscape Report 2026
16 October 2026
NCT07008378 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.